⌘K

Login Start Free

Home/Filings/4/0001209191-03-030182

4//SEC Filing

MELLIN MARK 4

Accession 0001209191-03-030182

CIK 0001001915other

View on SEC.gov Company Profile

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 4:29 PM ET

Size

5.3 KB

Accession

0001209191-03-030182

Insider Transaction Report

Form 4

Period: 2003-11-12

ILEX ONCOLOGY INCILXO

Senior Vice President & CFO

Transactions

Exercise/Conversion
Common Stock
2003-11-12$5.78/sh−3,000$17,340→ 72,000 total
Exercise: $5.78From: 2003-09-03Exp: 2012-09-03→ Common Stock (3,000 underlying)
Exercise/Conversion
Common Stock
2003-11-12$5.78/sh+3,000$17,340→ 3,000 total

Footnotes (1)

[F1]On 9/3/03, 18,750 shares vested. The remaining options vest in increments of 18,750 shares on 9/3/04, 9/3/05, and 9/3/06.

Documents

1 file

4
bsa10648_bdn2mm.xmlPrimary
MAIN DOCUMENT DESCRIPTION

Issuer

ILEX ONCOLOGY INC

CIK 0001001915

Entity typeother

Related Parties

1

filerCIK 0001201043

Filing Metadata

Form type: 4
Filed: Nov 12, 7:00 PM ET
Accepted: Nov 13, 4:29 PM ET
Size: 5.3 KB

View on SEC.gov